Author(s): Arzuaga NO, Vila Granda A, Gmez JC, San Miguel ME, Bourzac JF,
Abstract Share this page
Abstract Tuberculosis is one of the leading causes of mortality produced by an infectious agent. Different strategies including bioinformatics are currently being tested to identify and improve vaccines against tuberculosis. Comparative genome analysis between Streptomyces coelicolor and Mycobacterium tuberculosis suggest that both descend from a common Actinomycete ancestor. In this work, we suggest the use of Streptomyces as a live vector and explore the capacity of Streptomyces immunization to induce a protective response against mycobacterial infection. First, we compared the theoretical proteomes of S. coelicolor A3(2) with those of M. tuberculosis H37Rv and Mycobacterium bovis AF2122/97. This study showed a high similarity at the level of individual genes sequences with both bacteria sharing several membrane proteins. Then, we administered Streptomyces intraperitoneally to mice and determined its distribution by histopathology and culture; we did not find systemic dissemination. After administration of Streptomyces through different routes, we identified the most immunogenic, inducing strong humoral response, as denoted by the high serum antibody titers against this organism with cross reactivity to mycobacterial antigens. Finally, we evaluated the level of protection elicited by the inoculation of Streptomyces in Balb/c mice challenged with BCG. In these animals, lung bacillary loads were significantly lower than the control non-sensitized group.. These observations, along with Streptomyces' potential for expressing foreign proteins, suggest that Streptomyces could be an advantageous vector in the design of new tuberculosis vaccines.
This article was published in Hum Vaccin
and referenced in Journal of Cytology & Histology